Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

2.860
-0.125-4.19%
Volume:5.38M
Turnover:14.84M
Market Cap:1.09B
PE:-3.06
High:3.085
Open:2.980
Low:2.410
Close:2.985
52wk High:22.560
52wk Low:2.410
Shares:380.07M
HK Float Shares:375.46M
Volume Ratio:0.93
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.936
ROE:-70.66%
ROA:-28.19%
PB:3.56
PE(LYR):-3.06
PS:8686.63

Loading ...

TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.65%

HK Disclosure
·
Sep 11

TYK Medicines Reminds H Shareholders to Switch to Electronic Delivery of Corporate Communications

Bulletin Express
·
Sep 11

TYK Medicines Issues 11 September 2026 Reminder on Shift to Electronic Dissemination of Corporate Communications

Bulletin Express
·
Sep 11

TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million

Reuters
·
Sep 11

TYK Medicines-B (02410): Short-Term Volatility Masks Long-Term Strength, Insider Buying and Solid Fundamentals Open Up an Attractive Entry Point

Stock News
·
Sep 11

TYK Medicines CEO Boosts Shareholding; Shares Jump 7%

MT Newswires Live
·
Sep 11

Hong Kong Stock Market Flash | TYK Medicines-B Surges Over 9% as Chairman's Share Buyback Reinforces Confidence and Novel EGFR-TKI Gains Landmark Approval

Stock News
·
Sep 11

TYK Medicines Says Chairman Buys 635,000 H Shares Between Sept 8 and Sept 10, 2026

Reuters
·
Sep 11

Tyk Medicines - Share Purchase for Hk$2.09 Mln

THOMSON REUTERS
·
Sep 10

Tyk Medicines - Chairman Buys 635,000 H Shares Between Sept 8 and Sept 10, 2026

THOMSON REUTERS
·
Sep 10

TYK Medicines Chairman Wu Yusheng Buys 635,000 H Shares for Hk$2.09 Million

Reuters
·
Sep 10

TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.59%

HK Disclosure
·
Sep 10

TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.57%

HK Disclosure
·
Sep 09

TYK Medicines' Chairman Boosts Stake; Shares Down 8%

MT Newswires Live
·
Sep 09

TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase

Stock News
·
Sep 08

Tyk Medicines - Increase in Shareholding by CEO Will not Exceed HK$2 Mln

THOMSON REUTERS
·
Sep 08

Tyk Medicines - Chairman, CEO DR. Wu Yusheng Purchases Shares of Tyk Medicines on Open Market

THOMSON REUTERS
·
Sep 08

Insider Sellers Might Regret Selling TYK Medicines Shares at a Lower Price Than Current Market Value

Simply Wall St.
·
Sep 01

Regulatory Approval Granted to TY-9591, a Novel Targeted Therapy for EGFR-Mutant Lung Cancer With Brain Metastases

Stock News
·
Aug 28

Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval

Deep News
·
Aug 28